Progression of coronary artery calcification seems to be inevitable, but predictable-results of the Heinz Nixdorf Recall (HNR) study

European Heart Journal

Volumn 35, Issue 42, 2014, Pages 2960-2971a

  Erbel, Raimund ^a   Lehmann, Nils ^b   Churzidse, Sofia ^a   Rauwolf, Michael ^a   Mahabadi, Amir A ^a   Mohlenkamp, Stefan ^a,c   Moebus, Susanne ^b   Bauer, Marcus ^a   Kalsch, Hagen ^a   Budde, Thomas ^d   Montag, Michael ^d   Schmermund, Axel ^e   Stang, Andreas ^f,g   Dagmar, Fuhrer Sakel ^b   Weimar, Christian ^b   Roggenbuck, Ulla ^b   Dragano, Nico ^h   HeinzJockel, Karl ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c Krankenhaus Bethanien   (Germany)

^d Alfred Krupp Hospital   (Germany)

^e Cardioangiological Center Bethanien   (Germany)

^f MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^g BOSTON UNIVERSITY   (United States)

^h HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Coronary artery calcification; CT; Epidemiology; Heinz Nixdorf Recall study; Imaging; Progression of atherosclerosis

Indexed keywords

ANTILIPEMIC AGENT; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT TOOL; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; EARLY DIAGNOSIS; EPIDEMIOLOGY; GERMANY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; VASCULAR CALCIFICATION;

AGED; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; EARLY DIAGNOSIS; EPIDEMIOLOGIC METHODS; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; VASCULAR CALCIFICATION;

EID: 84912103644     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu288     Document Type: Article

References (36)

1. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832.
2. Min JK, Lin FY, Gidseg DS, Weinsaft JW, Weinsaft JW, Berman DS, Shaw LJ, Rozanski A, Callister TQ. Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the 'warranty period' for remaining normal? J Am Coll Cardiol 2010;55:1110-1117.
3. Raggi P, Cooil B, Ratti C, Callister TQ, Budoff M. Progression of coronary artery calcium and occurrence of myocardial infarction in patients with and without diabetes mellitus. Hypertension 2005;46:238-243.
4. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, Lauer MS, Post WS, Raggi P, Redberg RF, Rodgers GP, Shaw LJ, Taylor AJ, Weintraub WS. ACCF/AHA 2007 clinical expert consensus documentoncoronary artery calcium scoringbycomputedtomographyinglobal cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document onElectron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2007;49:378-402.
5. Budoff MJ, Hokanson JE, Nasir K, Shaw LJ, Kinney GL, Chow D, Demoss D, Nuguri V, Nabavi V, Ratakonda R, Berman DS, Raggi P. Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc Imaging 2010;3:1229-1236.
6. Erbel R, Lehmann N, Möhlenkamp S, Churzidse S, Bauer M, Kälsch H, Schmermund A, Moebus S, Stang A, Roggenbuck U, Bröcker-Preuss M, Dragano N, Weimar C, Siegrist J, Jöckel KH; Heinz Nixdorf Recall Study Investigators. Subclinical coronary atherosclerosis predicts cardiovascular risk in different stages of hypertension: result of the Heinz Nixdorf Recall Study. Hypertension 2012;59:44-53.
7. Erbel R, Lehmann N, Churzidse S, Möhlenkamp S, Moebus S, Mahabadi AA, Schmermund A, Stang A, Dragano N, Grönemeyer D, Seibel R, Kälsch H, Bauer M, Bröcker-Preuss M, Mann K, Jöckel KH; Heinz Nixdorf Recall Study Investigators. Gender-specific association of coronary artery calcium and lipoprotein parameters: The Heinz Nixdorf Recall Study. Atherosclerosis 2013;229:531-540.
8. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet 2005;366: 1267-1278.
9. Arad Y, Spadaro LA, Roth M, Newstein D, Guerci AD. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: The St. Francis Heart Study randomized clinical trial. J Am Coll Cardiol 2005;46:166-172.
10. Raggi P, Davidson M, Callister TQ, Welty FK, Bachmann GA, Hecht H, Rumberger JA. Aggressive versus moderate lipid-lowering therapy in hypercholes-terolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation 2005;112:563-571.
11. Houslay ES, Cowell SJ, Prescott RJ, Reid J, Burton J, Northridge DB, Boon NA, Newby DE; Scottish Aortic Stenosis and Lipid Lowering Therapy, Impact on Regression trial Investigators. Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial. Heart 2006;92:1207-1212.
12. Schmermund A, Achenbach S, Budde T, Buziashvili Y, Förster A, Erbel R. Effect of intensive versus standard lipid-lowering treatment with multicenter, randomized, double-blind trial. atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: multicenter, randomized, double-blind trial. Circulation 2006; 113:427-437.
13. Schmermund A, Lehmann N, Bielak LF, Yu P, Yu P, Yu P, Sheedy PF II, Cassidy-Bushrow AE, Turner ST, Moebus S, Möhlenkamp S, Stang A, Mann K, Jöckel KH, Erbel R, Peyser PA. Comparison of subclinical coronary atherosclerosis and risk factors in unselected populations in Germany and US-America. Atherosclerosis 2007;195:e207-e216.
14. McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distributionof coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2006;113:30-37.
15. Cassidy-Bushrow AE, Bielak LF, Sheedy PF 2nd, Turner ST, Kullo IJ, Lin X, Peyser PA. Coronary artery calcification progression is heritable. Circulation 2007;116:25-31.
16. Leopold JA. Vascular calcification. An age-old problem of old age. Circulation 2013; 127:2380-2382.
17. Lehmann N, MöhlenkampS, Mahabadi AA, Schmermund A, Roggenbuck U, Seibel R, Grönemeyer D, Budde T, Dragano N, Stang A, Mann K, Moebus S, Erbel R, Jöckel KH. Effect of smoking and other traditional risk factors on the onset of coronary artery calcification: results of the Heinz Nixdorf recall study. Atherosclerosis 2014;232: 339-345.
18. Stang A, Moebus S, Dragano N, Beck EM, Möhlenkamp S, Schmermund A, Siegrist J, Erbel R, Jöckel KH. Baseline recruitment and analyses of nonresponse of the Heinz Nixdorf Recall Study: identifiability of phone numbers as the major determinant of response. Eur J Epidemiol 2005;20:489-496.
19. Erbel R, Möhlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A, Dragano N, Grönemeyer D, Seibel R, Kälsch H, Brö cker-Preuss M, Mann K, Siegrist J, Jöckel KH; Heinz Nixdorf Recall Study Investigative Group. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol 2010;56:1397-1406.
20. Jöckel KH, Lehmann N, Jaeger BR, Moebus S, Möhlenkamp S, Schmermund A, Dragano N, Stang A, Grönemeyer D, Seibel R, Mann K, Volbracht L, Siegrist J, Erbel R.; Heinz Nixdorf Recall Study Investigative Group. Smoking cessation and sub-clinical atherosclerosis-results from the Heinz Nixdorf Recall Study. Atherosclerosis 2009;203:221-227.
21. Moebus S, Stang A, Möhlenkamp S, Dragano N, Schmermund A, Slomiany U, Hoffmann B, Bauer M, Broecker-Preuss M, Mann K, Siegrist J, Erbel R, Jöckel KH; Heinz Nixdorf Recall Study Group. Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort-results of the Heinz Nixdorf Recall Study. Diabetologia 2009;52: 81-89.
22. Erbel R, Delaney JA, Lehmann N, McClelland RL, Möhlenkamp S, Kronmal RA, Schmermund A, Moebus S, Dragano N, Stang A, Jöckel KH, Budoff MJ; Multi-Ethnic Study of Atherosclerosis; Investigator Group of the Heinz Nixdorf Recall Study. Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR). Eur Heart J 2008;29:2782-2791.
23. Kronmal RA, McClelland RL, Detrano R, Shea S, Lima JA, Cushman M, Bild DE, Burke GL. Risk factors for the progression of coronary artery calcification anasymp-tomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2007;115:2722-2730.
24. Allam AH, Thompson RC, Wann LS, Miyamoto MI, Nur El-Din Ael-H, El-Maksoud GA, Al-Tohamy Soliman M, Badr I, El-Rahman Amer HA, Sutherland ML, Sutherland JD, Thomas GS. Atherosclerosis in ancient Egyptian mummies: the Horus study. JACC Cardiovasc Imaging 2011;4:315-327.
25. Thompson RC, Allam AH, Lombardi GP, Wann LS, Sutherland ML, Sutherland JD, Soliman MA, Frohlich B, Mininberg DT, Monge JM, Vallodolid CM, Cox SL, Abd el-Maksoud G, Badr I, Miyamoto MI, el-Halim Nur el-Din A, Narula J, Finch CE, Thomas GS. Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations. Lancet 2013;381:1211-1222.
26. Bild DE, Detrano R, Peterson D, Guerci A, Liu K, Shahar E, Ouyang P, Jackson S, Saad MF. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2005;111:1313-1320.
27. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998;18:45-48.
28. Siffert W, Forster P, Jöckel K-H, Mvere DA, Brinkmann B, Naber C, Crookes R, Du P, Heyns A, Epplen JT, Fridey J, Freedman BI, Müller N, Stolke D, Sharma AM, Al Moutaery K, Grosse-Wilde H, Buerbaum B, Ehrlich T, Ahmad HR, Horsthemke B, Du Toit ED, Tiilikainen A, Ge J, Wang Y, Rosskopf D. Worldwide ethmic distribution of the G protein ß3 subunit 826T allele and its association with obesity in Caucasian, Chinese, and Black African Individuals. J Am Soc Nephrol 1999;10:1921-1930.
29. Kiramijyan S, Ahmadi N, Isma'eel H, Flores F, Shaw LJ, Raggi P, Budoff MJ. Impact of coronary artery calcium progression and statin therapy on clinical outcome in subjects with and without diabetes mellitus. Am J Cardiol 2013;111:356-361.
30. Quercioli A, Montecucco F, Pataky Z, Thomas A, Ambrosio G, Staub C, Di Marzo V, Ratib O, Mach F, Golay A, Schindler TH. Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines. Eur Heart J 2013;34: 2063-2073.
31. Okwuosa TM, Greenland P, Burke GL, Eng J, Cushman M, Michos ED, Ning H, Lloyd-Jones DM. Prediction of coronary artery calcium progression in individuals with low Framingham Risk Score: the Multi-Ethnic Study of Atherosclerosis. JACC Cardiovasc Imaging 2012;5:144-153.
32. Reinsch N, Mahabadi AA, Lehmann N, Möhlenkamp S, Hoefs C, Sievers B, Budde T, Seibel R, Jöckel KH, Erbel R. Comparison of dual-source and electron-beam CT for the assessment of coronary artery calcium scoring. Br J Radiol 2012;85:e300-e306.
33. Erbel R, Möhlenkamp S, Kerkhoff G, Budde T, Schmermund A. Non-invasive screening for coronary artery disease: calcium scoring. Heart 2007;93:1620-1629.
34. Möhlenkamp S, Erbel R. Prognostic significance of coronary calcification in asymptomatic persons. Münch Med Wschr, Fortschr Med 2007;149:38-40.
35. Erbel R, Budoff M. Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: the memory of lifetime risk factor exposure. Eur Heart J 2012;33:1201-1213.
36. Budoff M, Budoff MJ, Möhlenkamp S, McClelland R, Delaney JA, Bauer M, Jöckel HK, Kälsch H, Kronmal R, Nasir K, Lehmann N, Moebus S, Mukamal K, Erbel R; Multi Ethnic Study of Atherosclerosis and the Investigator Group of the Heinz Nixdorf RECALL Study. A comparison of outcomes with coronary artery calcium scanning in unselected populations: the Multi-Ethnic Study of Atherosclerosis (MESA) and Heinz Nixdorf RECALL study (HNR). J Cardiovasc Comput Tomogr 2013;7:182-191.